Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Warner, J. Trinidad, B. Bastian, A. Miniño, H. Hedegaard (2016)
Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2010-2014.National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, 65 10
B. Berkowitz (1976)
The Relationship of Pharmacokinetics to Pharmacological Activity: Morphine, Methadone and NaloxoneClinical Pharmacokinetics, 1
E. Nyenwe, R. Loganathan, S. Blum, D. Ezuteh, D. Erani, J. Wan, M. Palace, A. Kitabchi (2007)
Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 13 1
Hedegaard (2018)
1National Vital Statistics Reports, 67
T. Tzeng, I. Liu, Ty Lai, CC Tsai, WC Chang, J. Cheng (2003)
Loperamide increases glucose ultilization in streptozotocin‐induced diabetic ratsClinical and Experimental Pharmacology and Physiology, 30
Tigran Makunts, A. U, Rabia Atayee, R. Abagyan (2019)
Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioidsScientific Reports, 9
Elizabeth Warner, Greene Gs, Michael Buchsbaum, David Cooper, Bruce Robinson (1998)
Diabetic ketoacidosis associated with cocaine use.Archives of internal medicine, 158 16
A. Bryan (1994)
Diabetic ketoacidosis.British journal of nursing, 3 17
Lux (1988)
187Journal of Pharmacology and Experimental Therapeutics, 245
J. Flory, A. Wiesenthal, H. Thaler, L. Koranteng, N. Moryl (2016)
Methadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain.Journal of pain and symptom management, 51 1
Davood Soroosh, Z. Zakariaei, H. Azadeh, R. Tabaripour, E. Banimostafavi (2021)
Occurrence of hypoglycemia in patients with benzodiazepines poisoning: A cross-sectional studyAnnals of Medicine and Surgery, 69
A. Ceriello, D. Giugliano, N. Passariello, A. Quatraro, P. Dellorusso, R. Torella, F. D'onofrio (1987)
Impaired Glucose Metabolism in Heroin and Methadone UsersHorm. metabol. Res., 19
A. Yassen, E. Olofsen, E. Dorp, E. Sarton, L. Teppema, M. Danhof, A. Dahan (2007)
Mechanism-Based Pharmacokinetic-Pharmacodynamic Modelling of the Reversal of Buprenorphine-Induced Respiratory Depression by NaloxoneClinical Pharmacokinetics, 46
J. Evans, M. Hogg, J. Lunn, M. Rosen (1974)
Degree and Duration of Reversal by Naloxone of Effects of Morphine in Conscious SubjectsBritish Medical Journal, 2
Lux (1989)
688Journal of Pharmacology and Experimental Therapeutics, 249
E. Olofsen, Eveline Dorp, L. Teppema, L. Aarts, Terry Smith, A. Dahan, E. Sarton (2010)
Naloxone Reversal of Morphine- and Morphine-6-Glucuronide-induced Respiratory Depression in Healthy Volunteers: A Mechanism-based Pharmacokinetic–Pharmacodynamic Modeling StudyAnesthesiology, 112
F. Lux, Y. Han, D. Brase, W. Dewey (1989)
Studies on the mechanism of hypoglycemia induced by intrathecal morphine: dissociation from behavioral effects, effects of tolerance and depletion of liver glycogen.The Journal of pharmacology and experimental therapeutics, 249 3
A. Faskowitz, Vladimir Kramskiy, G. Pasternak (2013)
Methadone-Induced HypoglycemiaCellular and Molecular Neurobiology, 33
F. Lux, D. Brase, W. Dewey (1988)
Differential effects of subcutaneous and intrathecal morphine administration on blood glucose in mice: comparison with intracerebroventricular administration.The Journal of pharmacology and experimental therapeutics, 245 1
A. Yassen, E. Olofsen, E. van Dorp, E. Sarton, L. Teppema, M. Danhof, A. Dahan (2007)
Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone: A study in healthy volunteersClinical Pharmacokinetics, 46
Literature has found that individuals with opioid use disorders have increased fasting insulin levels and that antagonism of the μ-receptor with naloxone blunted this hypoglycemic effect. We describe a 35-year-old woman with no history of diabetes who presented after being found unconscious where she was given naloxone and became awake and combative. Her blood glucose (BG) on presentation was 175 mg/dl, which declined to 40 mg/dl, and dextrose was administered. Subsequently, it declined to 42 mg/dl and was again given dextrose. Later her BG fell to 67 mg/dl and she was given dextrose and started on a dextrose infusion. She was then administered IV naloxone and 1 hr later the infusion was discontinued and she had no further hypoglycemic events. Clinicians should consider altering monitoring parameters in the setting of acute overdoses to include repeated glucose assessment to ensure early identification of hypoglycemia and the potential influence of naloxone.
Advanced Emergency Nursing Journal – Wolters Kluwer Health
Published: Apr 1, 2023
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.